Cholesterol suppresses antimicrobial effect of statins

Area of Science:

• Microbiology and Biochemistry
• Bacterial membrane biogenesis
• Isoprenoid biosynthesis pathway

Background:

• Isoprenoid biosynthesis is crucial for producing biomolecules like cholesterol and carotenoids essential for cell membranes.
• Statins, known cholesterol-lowering drugs, may possess direct antimicrobial effects on certain bacteria.
• The precise mechanism of statin action in microbial metabolism, particularly concerning membrane integrity, remains unclear.

Purpose of the Study:

• To investigate whether statins inhibit the production of essential bacterial membrane compounds.
• To determine if cholesterol can counteract the toxic effects of statins on bacteria by replacing inhibited metabolites.

Main Methods:

• Assessed the antibacterial effects of lovastatin, simvastatin, and atorvastatin.
• Tested statins alone and in combination with cholesterol against Gram-positive (Staphylococcus aureus, Enterococcus faecalis) and Gram-negative (Pseudomonas aeruginosa, Escherichia coli) bacteria.
• Utilized the gel diffusion assay to evaluate antimicrobial activity.

Main Results:

• Simvastatin and atorvastatin demonstrated significant antibacterial activity against Staphylococcus aureus, Escherichia coli, and Enterococcus faecalis.
• Lovastatin did not exhibit significant antibacterial properties in this study.
• Cholesterol effectively nullified the antimicrobial action of the effective statins in sensitive bacterial strains.

Conclusions:

• Statins may inhibit the synthesis or utilization of a critical metabolite required for bacterial membrane stability.
• Cholesterol can substitute for this statin-inhibited metabolite, thereby rescuing bacteria from the drug's toxic effects.
• These findings suggest a potential therapeutic strategy involving cholesterol to mitigate statin-induced antimicrobial effects.